Literature DB >> 9276417

Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.

Y Liu1, B J Mee, L Mulgrave.   

Abstract

In a collection of 43 indole-positive Klebsiella clinical isolates, which were initially identified as Klebsiella oxytoca, there were 18 isolates which exhibited a pattern characteristic of extended-spectrum beta-lactamase (ESBL) resistance. This study aimed to confirm their identity by biochemical tests and by PCR and to determine the genetic basis for their resistance to the beta-lactams and broad-spectrum cephalosporins. Chromosomal beta-lactamase genes were analyzed by PCR, and plasmid-mediated beta-lactamase genes were analyzed by conjugation and transformation. There were 39 isolates which grew on melezitose but failed to grow on 3-hydroxybutyrate, confirming them as K. oxytoca. PCR analysis of their beta-lactamase genes divided these isolates into two groups, the bla(OXY-1) group and the bla(OXY-2) group. Each group had beta-lactamases with different isoelectric points; the bla(OXY-1) group had beta-lactamases with isoelectric points at 7.2, 7.8, 8.2, and 8.8, and the more common bla(OXY-2) group had beta-lactamases with pIs at 5.2, 5.4 (TEM-1), 5.7, 5.9, 6.4, and 6.8. A pI of 5.2 was the most frequently detected and accounted for 59% of all the bla(OXY-2) beta-lactamases. Hyperproduction of clavulanate-inhibited chromosomal beta-lactamases was detected in 17 K. oxytoca isolates, resulting in an ESBL phenotype. K. oxytoca isolates having a plasmid-mediated genetic basis for their ESBL phenotype were not found, confirming that, in K. oxytoca, plasmids are rarely involved in conferring resistance to the newer cephalosporins. Four isolates proved to be isolates of K. planticola in which the beta-lactamase genes failed to react with the primers used in the PCR. One K. planticola isolate contained a transferable plasmid harboring the SHV-5 beta-lactamase gene and showed an ESBL phenotype, while the other non-ESBL K. planticola isolates contained chromosomal beta-lactamases with isoelectric points at 7.2, 7.7, and 7.9 plus 7.2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276417      PMCID: PMC229969          DOI: 10.1128/jcm.35.9.2365-2369.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Rapid plasmid DNA isolation from mucoid gram-negative bacteria.

Authors:  P Domenico; J L Marx; P E Schoch; B A Cunha
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

3.  Klebsiella pneumonia strains moderately resistant to ampicillin and carbenicillin: characterization of a new beta-lactamase.

Authors:  R Labia; C Fabre; J M Masson; M Barthelemy; M Heitz; J S Pitton
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

4.  Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.

Authors:  B Fournier; C Y Lu; P H Lagrange; R Krishnamoorthy; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

5.  Characterization of an SHV-5 related extended broad-spectrum beta-lactamase in Enterobacteriaceae from Western Australia.

Authors:  L Mulgrave; P V Attwood
Journal:  Pathology       Date:  1993-01       Impact factor: 5.306

Review 6.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

7.  Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.

Authors:  B Fournier; P H Roy; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  Method for differentiating Klebsiella planticola and Klebsiella terrigena from other Klebsiella species.

Authors:  D Monnet; J Freney
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  A survey of beta-lactamases from 618 isolates of Klebsiella spp.

Authors:  R Reig; C Roy; M Hermida; D Teruel; A Coira
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

Review 10.  beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact.

Authors:  C C Sanders; W E Sanders
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

View more
  10 in total

1.  Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.

Authors:  S W Wu; K Dornbusch; G Kronvall
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Extended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria.

Authors:  I E Aibinu; V C Ohaegbulam; E A Adenipekun; F T Ogunsola; T O Odugbemi; B J Mee
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Enterobacterial repetitive intergenic consensus 1R PCR assay for detection of Raoultella sp. isolates among strains identified as Klebsiella oxytoca in the clinical laboratory.

Authors:  Sophie A Granier; Véronique Leflon-Guibout; Fred W Goldstein; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.

Authors:  S W Wu; K Dornbusch; G Kronvall; M Norgren
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Identification of clinical isolates of indole-positive and indole-negative Klebsiella spp.

Authors:  Maria Silvana Alves; Rubens Clayton da Silva Dias; Angela Christina Dias de Castro; Lee W Riley; Beatriz Meurer Moreira
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

6.  Recommended test panel for differentiation of Klebsiella species on the basis of a trilateral interlaboratory evaluation of 18 biochemical tests.

Authors:  Dennis S Hansen; Hazel M Aucken; Titi Abiola; Rainer Podschun
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  Analysis of the 16S-23S rRNA gene internal transcribed spacer region in Klebsiella species.

Authors:  Min Wang; Boyang Cao; Qunfang Yu; Lei Liu; Qili Gao; Lei Wang; Lu Feng
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

8.  Genome sequence of Klebsiella oxytoca 11492-1, a nosocomial isolate possessing a FOX-5 AmpC β-lactamase.

Authors:  Tracy H Hazen; Gwen L Robinson; Anthony D Harris; David A Rasko; J Kristie Johnson
Journal:  J Bacteriol       Date:  2012-06       Impact factor: 3.490

9.  Genetic and biochemical characterization of the chromosomal class A beta-lactamases of Raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica.

Authors:  Estelle Walckenaer; Laurent Poirel; Véronique Leflon-Guibout; Patrice Nordmann; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Indole and 7-hydroxyindole diminish Pseudomonas aeruginosa virulence.

Authors:  Jintae Lee; Can Attila; Suat L G Cirillo; Jeffrey D Cirillo; Thomas K Wood
Journal:  Microb Biotechnol       Date:  2008-10-14       Impact factor: 5.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.